Invention Application
US20160081947A1 SELECTIVE LSD1 AND DUAL LSD1/MAO-B INHIBITORS FOR MODULATING DISEASES ASSOCIATED WITH ALTERATIONS IN PROTEIN CONFORMATION 审中-公开
选择性LSD1和双LSD1 / MAO-B抑制剂调节与蛋白质配合变化相关的疾病

  • Patent Title: SELECTIVE LSD1 AND DUAL LSD1/MAO-B INHIBITORS FOR MODULATING DISEASES ASSOCIATED WITH ALTERATIONS IN PROTEIN CONFORMATION
  • Patent Title (中): 选择性LSD1和双LSD1 / MAO-B抑制剂调节与蛋白质配合变化相关的疾病
  • Application No.: US14675990
    Application Date: 2015-04-01
  • Publication No.: US20160081947A1
    Publication Date: 2016-03-24
  • Inventor: Tamara MAESCarlos BUESA ARJOL
  • Applicant: ORYZON GENOMICS S.A.
  • Main IPC: A61K31/135
  • IPC: A61K31/135 A61K31/495 A61K31/165
SELECTIVE LSD1 AND DUAL LSD1/MAO-B INHIBITORS FOR MODULATING DISEASES ASSOCIATED WITH ALTERATIONS IN PROTEIN CONFORMATION
Abstract:
The invention relates to methods and compositions for the treatment or prevention of protein conformation disorders. In particular, the invention relates to an LSD1 inhibitor for use in treating or preventing a protein conformation disorder, such as, e.g., Huntington Disease.
Information query
Patent Agency Ranking
0/0